CLINICAL_TRIALS
trial_result
· 2023-06-09
Clinical Trial Update: Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia [Phase 2]
Summary
Phase 2 clinical trial update for Avexitide evaluating safety and efficacy in acquired hyperinsulinemic hypoglycemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Tracey McLaughlin, MD | Conditions: Acquired Hyperinsulinemic Hypoglycemia | Phase 2 | Status: COMPLETED | Results posted: 2023-06-09